Migraine Medications: Triptans, Gepants, and Ditans Safety Compared

When a migraine hits, you don’t just want relief-you want it fast, without making things worse. But not all migraine meds are created equal when it comes to safety. Triptans, gepants, and ditans all treat acute attacks, but their side effect profiles are wildly different. Knowing which one carries the least risk for you could mean the difference between getting back to your day-or being stuck on the couch for hours.

Triptans: Fast Relief, But With a Cost

Triptans have been the go-to for decades. Sumatriptan, the first one approved in 1991, works by narrowing blood vessels around the brain and blocking pain signals. That’s why many people feel relief in under 30 minutes. But that same mechanism is also why they come with red flags.

Between 3% and 8% of users report chest tightness or pressure after taking a triptan. It’s not a heart attack, but it feels terrifying. Some people stop using them after that first scary experience. Other common side effects include tingling in the hands or face (8-15%), dizziness (7-14%), and fatigue (5-9%). If you use the injection form, 40% report pain at the injection site. Nasal sprays leave a bitter aftertaste for about a quarter of users.

Here’s the real catch: triptans are off-limits if you have heart disease, high blood pressure, uncontrolled diabetes, or a history of stroke. Even if you’ve taken them safely before, your risk can change over time. The American Academy of Family Physicians warns against using triptans within 24 hours of dihydroergotamine-combining them can dangerously constrict blood vessels.

Still, they’re effective. A 2021 review of 64 clinical trials found triptans reduced pain at two hours better than newer options. But nearly 60% of users report stopping them due to side effects. That’s a lot of people giving up on something that works, just because the side effects aren’t worth it.

Gepants: The Quiet Contender

Gepants-like ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT)-work differently. Instead of squeezing blood vessels, they block a brain chemical called CGRP, which plays a big role in migraine pain. This means no vasoconstriction. No chest tightness. No risk for people with heart conditions.

Their safety profile is the cleanest of the three. Nausea affects only 4-6% of users. Drowsiness? Just 2-4%. One small risk: rimegepant has caused allergic reactions in 0.1% of users. That’s rare, but worth noting if you’ve ever had a weird reaction to a new pill.

They’re not perfect. Gepants take longer to work-usually 60 to 90 minutes-compared to triptans’ 30. And they’re more expensive. But if you’ve been scared off by triptans, or if you have high blood pressure or a history of heart issues, gepants are now the first-line recommendation from the American Headache Society.

One big plus: rimegepant is also approved for prevention. You can take it once a day to cut down on migraine frequency, or use it as needed. That flexibility makes it a standout. Long-term data is still growing, but two-year studies on rimegepant show it’s safe for ongoing use.

Ditans: Powerful, But Too Sedating

Lasmiditan (Reyvow) is the only ditan on the market. It targets a different serotonin receptor than triptans, so it doesn’t constrict blood vessels. That sounds great-until you feel the side effects.

In clinical trials, nearly 19% of people taking lasmiditan reported dizziness. That’s almost double the placebo group. Sedation hit 7.8%-nearly four times higher than placebo. People described feeling "out of it," "drunk without alcohol," or "like a zombie." One Reddit user wrote: "I couldn’t drive home. I had to sleep in the car for two hours."

The FDA requires a black box warning: don’t drive or operate machinery for at least eight hours after taking it. That’s not a suggestion. It’s a rule. And if you have a history of seizures or take other meds that lower your seizure threshold, you should avoid it entirely.

It’s not that lasmiditan doesn’t work-it does. But for most people, the trade-off isn’t worth it. Why take a drug that knocks you out for half a day when you just want to get through your workday? It’s become a niche option, used mostly when triptans and gepants fail.

How Do They Compare Side by Side?

Here’s what the data says about safety:

The numbers tell a clear story. Gepants win on safety. Ditans win on worst side effects. Triptans win on speed-but at the cost of tolerability.

Real People, Real Experiences

On Drugs.com, triptans average a 6.4/10. Many users say they work fast but can’t handle the chest pressure. One wrote: "Sumatriptan works within 30 minutes and gets me back to normal." Another: "Experienced severe chest pressure with first dose of Imitrex-never using it again."

Gepants score higher: 7.1/10. People like rimegepant because "no chest pressure like with triptans, just takes longer to work." That’s the trade-off: patience for peace of mind.

Lasmiditan? Only 5.8/10. Over 60% of negative reviews mention dizziness or sedation. One user said: "Felt completely out of it for 6 hours after taking Reyvow-can’t function at work." On Reddit, posts with "Reyvow made me feel drunk without alcohol" got over 140 upvotes. People aren’t exaggerating.

What Should You Do?

If you’ve never tried a migraine med before:

• Start with a gepant if you have heart issues, high blood pressure, or a family history of stroke.
• Try a triptan if you need fast relief and have no cardiovascular risks.
• Avoid ditans unless other options have failed and you can afford to be sedated for hours.

If you’ve tried one and stopped:

• Did triptans make your chest feel tight? Switch to a gepant.
• Did lasmiditan leave you too groggy? Go back to triptans-or try a gepant.

Side effects aren’t always the drug’s fault. Sometimes, what feels like dizziness or fatigue is just your migraine lingering. But if you’re consistently waking up worse than when you went to bed, it’s time to switch.

And if you’re on a triptan and feel fine? Keep using it. They’re still the most effective option for many. But if you’re on the fence, the safest bet today is a gepant.

What’s Next?

New options are coming. Zavegepant, an intranasal gepant, just finished phase 3 trials with fewer side effects than triptans. It might be available soon. Meanwhile, long-term safety data for gepants beyond two years is still being collected. But for now, the choice is clear: if safety matters most, gepants lead the pack.